UMAC holder files Form 144 to sell 10,000 common shares

Rhea-AI Filing Summary

UMAC has a Form 144 filing indicating that a holder plans to sell 10,000 shares of common stock through broker Maxim Group on the NYSE, with an aggregate market value of $91,000. The table shows 36,875,549 shares of common stock outstanding, providing context for the planned sale size.

The securities to be sold were acquired as restricted stock units from the issuer as compensation. One grant covers 8,334 shares dated 05/19/2025 and another covers 2,308 shares dated 08/19/2025, with payment noted as compensation on 11/20/2025. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group 300 Park Ave 16th Floor New York NY 10022	10000	91000.00	36875549	11/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/19/2025	Restricted Stock Units	Issuer			8334	11/20/2025	Compensation
Common Stock	08/19/2025	Restricted Stock Units	Issuer			2308	11/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the UMAC Form 144 filing disclose?

The filing discloses that a holder of UMAC common stock plans to sell 10,000 shares through Maxim Group on the NYSE, with an aggregate market value of $91,000.

How many UMAC shares are outstanding according to this Form 144?

The Form 144 lists 36,875,549 shares of UMAC common stock as outstanding, providing a baseline to gauge the relative size of the planned 10,000-share sale.

How were the UMAC shares in this Form 144 acquired?

The shares were acquired as restricted stock units from the issuer as compensation, with grants dated 05/19/2025 for 8,334 shares and 08/19/2025 for 2,308 shares.

Which broker is handling the proposed UMAC share sale in this Form 144?

The proposed sale of UMAC common stock is listed with Maxim Group, located at 300 Park Ave, 16th Floor, New York, NY 10022, as the broker.

On which exchange are the UMAC shares in this Form 144 expected to be sold?

The Form 144 indicates that the 10,000 UMAC common shares are planned to be sold on the NYSE.

What representation does the seller make in the UMAC Form 144?

By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.